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abstract: Multiple myeloma (MM) can present with involvement of the central nervous system in the form 
of nerve palsy, plasma cell masses or, rarely, with endocrinological effects due to involvement of the pituitary 
gland. Usually, in such cases, the disease has a rapid progression and poor prognosis. We report a 52-year-old man 
who was admitted to the Kolkata Medical College, Kolkata, India, in 2016 with a prolonged low-grade fever and 
hypernatremia. Shortly afterwards, the patient began to complain of increased urinary frequency and drowsiness. 
The hypernatremia was treated with intranasal desmopressin and free water replacement. Serum protein 
electrophoresis and an immunofixation study revealed an immunoglobulin G-κ monoclonal band. Magnetic 
resonance imaging of the pituitary gland revealed the absence of a posterior bright spot and spotty infiltration 
of the pituitary fossa. A bone marrow biopsy confirmed a diagnosis of cranial diabetes insipidus due to posterior 
pituitary MM infiltration.
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امللخ�ص: املايلوما املتعددة من املمكن اأن ت�ساحب خلل يف اجلهاز الع�سبي املركزي يظهر ك�سلل ع�سبي، اأو كتل خاليا البالزما اأونادرا 
�سلبية. ن�سجل هنا  يوؤدي اىل نتائج  النخامية. عادة، يف مثل هذه احلاالت يتطور املر�س ب�سكل �رشيع  الغدة  خلل هرموين ب�سبب تورط 
2016 ومعه حمى منخف�سة طويلة املدى وزيادة يف  الهند عام  الطبية يف  اأدخل اىل كلية كولكاتا  52 عاما  العمر  حالة رجل يبلغ من 
ن�سبة ال�سوديوم يف الدم. وبعد فرتة ق�سرية، بداأ املري�س ي�سكو من تكرار التبول والنعا�س. مت عالج زيادة ن�سبة ال�سوديوم باعطاء بعقار 
ديزموبري�سني من خالل االأنف واال�ستبدال باملياه املقطرة. ك�سف التحليل الكهربائي لربوتني م�سل الدم والدرا�سة بالتثبيت املناعي وجود 
بالرنني املغناطي�سي عدم وجود بقعة م�سيئه خلفية  النخامية  الغدة  االأحادي. وك�سف ت�سوير  )ج كابا(  املناعي اجللوبيولني  الربوتني 
ووجود بقع متخلله للحفرة النخامية. واأكدت خزعة نخاع العظم ت�سخي�س مر�س ال�سكري الكاذب يف اجلمجمة ب�سبب تغلغل املايلوما يف 
الغدة النخامية اخللفية.
الكلمات املفتاحية: ميولوما متعددة؛ مر�س ال�سكري الكاذب؛ الغدة النخامية؛ ازدياد ن�سبة ال�سوديوم بالدم؛ تقرير حالة؛ الهند.
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Multiple myeloma (MM) is a haemato-logical malignancy of the plasma cells which can affect multiple organs; in cases of neuro- 
logical involvement in MM, this may take different 
forms.1–3 While both the central and peripheral nervous 
systems may be affected, involvement of the central 
nervous system (CNS) is rare and the prognosis is 
usually quite poor.2 Usually, CNS involvement is 
observed in cases of established residual MM or 
during a subsequent relapse.3 This case report describes 
a patient with MM which manifested initially with 
cranial diabetes insipidus.
Case Report
A 52-year-old man was admitted to the Kolkata Medical 
College, Kolkata, India in 2016 with a low-grade fever 
of one month’s duration. He had been treated several 
times for a recurrent respiratory tract infection over 
the previous month. Upon admission, a clinical 
examination revealed pallor and mild dehydration. 
There was no evidence of organomegaly, bone tender-
ness or lymphadenopathy. The patient had no urinary 
complaints and weighed approximately 61 kg. As 
he had a fever with scattered crepitations in the 
chest cavity, he was initially treated for a respiratory 
tract infection. Initial blood investigations revealed 
haemoglobin levels of 6 g/dL, a total leukocyte count 
of 9,000/µL (neutrophils: 59%; lymphocytes: 30%; 
eosinophils: 6%) and a platelet count of 80,000/µL. 
His erythrocyte sedimentation rate was 110 mm in 
the first hour and his urea and creatinine levels were 
72.1 mg/dL and 1.6 mg/dL, respectively. His serum 
albumin level was 2.9 g/dL, his globulin level was 
10.4 g/dL and his serum calcium level was 8.6 mg/dL 
(corrected: 9.5 mg/dL). At admission, his blood serum 
sodium and potassium levels were 148 mEq/L and 
4 mEq/L, respectively. 
On the second day following admission, the 
patient suddenly complained of increased urinary 
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frequency both during the day and at night. His total 
daily urinary output was approximately 9 L while 
drinking a normal amount of water ad libitum. His 
24-hour urinary creatinine level was 1,100 mg and 
urinary osmolality was 250 mOsm. There was no 
evidence of increased thirst and the patient was 
not currently taking any diuretics or mannitol. His 
blood and urine glucose levels were also normal. A 
microscopic analysis of a urine sample did not reveal 
any evidence of infection. By the third day of admission, 
the patient had become drowsy. His blood sodium level 
was 170 mEq/L and urine osmolarity was 100 mOsm. 
As a result, free water replacement was immediately 
initiated at 100 mL/hour. Following a desmopressin 
challenge as per standard protocols, a dose of 10 
µg of desmopressin was administered intranasally 
thrice daily, as the intramuscular form of the drug 
was not available.4 Subsequently, the patient’s blood 
serum sodium levels gradually fell from 160 mEq/L 
on day four to 152 mEq/L on day five and 145 mEq/L 
on day six [Figure 1]. His urinary output decreased to 
5 L/day and then 3 L/day, respectively, on the first and 
second days after the administration of desmopressin. 
The patient’s consciousness level also improved. His 
blood pressure remained normal throughout the 
admission period. 
On the second day following admission, the 
patient underwent serum protein electrophoresis 
which revealed a monoclonal band in the γ-globulin 
region. According to an immunofixation study per-
formed on day six, the monoclonal globulin was 
an immunoglobulin G κ-light chain. The patient’s 
serum β2-microglobulin level was 1,800 µg/mL. 
Skeletal X-rays did not reveal any lytic lesions. A T1-
weighted magnetic resonance imaging (MRI) scan of 
the pituitary gland region on the seventh day revealed 
the absence of a posterior pituitary bright spot along 
with some infiltrations, likely from the underlying 
malignancy [Figure 2]. Although a cerebrospinal fluid 
(CSF) analysis was performed twice (on days three and 
seven), no plasma cells were seen. Levels of plasma 
cortisol and thyroid-stimulating hormone were also 
normal. 
A bone marrow biopsy performed on the 10th 
day following admission showed approximately 30% 
plasma cells with depressed erythropoiesis. The patient 
was thus diagnosed with MM and cranial diabetes 
insipidus due to posterior pituitary infiltration. A 
pituitary biopsy was not performed as the patient 
did not agree to the procedure. Additionally, in view 
of his severe dehydration and hypernatremia, a water 
deprivation test was not attempted, although the 
patient continued using an intranasal desmopressin 
spray. However, after being informed of the diagnosis, 
the patient refused further treatment and was 
subsequently lost to follow-up.
Discussion
In cases of MM, involvement of the CNS can manifest 
in different forms, including carcinomatous meningitis, 
cranial nerve palsy, quadriparesis or higher-function 
abnormalities such as dysphasia.3 These effects can 
occur as a result of the direct infiltration of the malig-
nant plasma cells, the development of plasmacytomas 
in the skull or because of metabolic derangements 
caused by the malignancy.3 Generally, most patients 
with CNS myelomas have a very poor prognosis.3 It is 
postulated that malignant plasma cells acquire certain 
molecular characteristics which enable them to invade 
the CNS and which also confer drug resistance; hence, 
any form of therapy is largely ineffective.3
 
Figure 1: Line graph showing changes in the blood 
serum sodium levels and urine osmolality of a 52-year-
old man with a prolonged low-grade fever and hyper-
natremia from the day of admission (Day 0) onwards. 
Intranasal desmopressin was administered from the 
third day onwards. The patient was subsequently 
diagnosed with diabetes insipidus.
 
Figure 2: T1-weighted magnetic resonance imaging of 
a 52-year-old man with a prolonged low-grade fever and 
hypernatremia showing the absence of a posterior pituitary 
bright spot (arrow) with spotty infiltration of the pituitary 
fossa (asterisk), likely due to multiple myeloma.
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Not all MM cases with pituitary masses are 
associated with diabetes insipidus. Mandagere et al. 
reported a 53-year-old woman with a sellar plasma-
cytoma which had only mass effects and no endocrine 
effects; this was resected completely with a relatively 
good outcome in which the patient remained disease- 
free for the following seven years.11 In the present 
case, the presence of features of diabetes insipidus 
indicated extension of the tumour beyond the sella 
turcica and thus surgical resection was not feasible. 
Patients with both MM and diabetes insipidus generally 
have a poorer prognosis.5 One unusual feature of 
the present case was the absence of increased thirst 
at the onset of diabetes insipidus. This feature is very 
rarely reported and is often associated with increased 
mortality.12 In the present case, this may have been due 
to simultaneous damage to the hypothalamic thirst 
centre, although there was no evidence of this on MRI. 
Management of diabetes insipidus without increased 
thirst is more complex because patients require daily 
assessments to ensure adequate water intake.12
Although the present case report is limited by 
a lack of definitive evidence from a pituitary biopsy, 
a few other cases of MM with pituitary involvement 
have been reported in which the diagnosis was also 
made presumptively.8 Taking a biopsy sample from the 
posterior pituitary gland is a technically demanding 
procedure and often not feasible in certain institutions. 
A CSF analysis is an indirect method of diagnosing 
MM, especially to rule out alternative diagnoses like 
infection.3 However, in the present case, a repeated 
CSF analysis was normal. 
Conclusion
This case report describes a patient with MM which 
manifested initially as cranial diabetes insipidus. In 
MM cases, involvement of the CNS is rare and generally 
has a very poor prognosis for affected patients; 
clinicians should therefore be aware of this potential 
manifestation. In addition, abnormally increased 
urinary output in a patient with MM should prompt 
investigations for concomitant diabetes insipidus.
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